Clinical Trial Update: Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia [EARLY_Phase 1]

View source ↗

Summary

This early-phase trial compares nilotinib to imatinib in patients with newly diagnosed chronic myeloid leukemia to assess safety and preliminary efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)
• Nilotinib (nilotinib)

Snippet

Sponsor: Assiut University | Conditions: Chronic Myeloid Leukemia | EARLY_Phase 1 | Status: UNKNOWN